Archives

by in
Entry Author Date Location
Viamet Pulls IPO, Raises $60M, Spins Off Cancer Program 10/21/14 Raleigh Durham
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
San Diego Life Sciences Roundup: Effector, Ignyta, and More 05/23/13 San Diego
Effector Therapeutics Raises $45M to Prove New Concept in Cancer 05/21/13 San Diego
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies 10/11/11 San Francisco
Cleave Biosciences Receives $42,000,000 Series A Financing Round 10/11/11 San Francisco
BuyWithMe Gets Edhance, LogMeIn Picks Up Pachube, Polaris Backs Two MA Companies, & More Boston-Area Deals News 07/20/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Verastem Obtains $32,000,000 Series B Financing Round 07/14/11 Boston
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs 07/07/11 National
Takeda Bets on Fate Therapeutics 05/10/11 San Diego
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News 10/01/10 Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News 09/29/10 Boston
Biotech DecImmune Grabs $1M from Astellas VC 09/27/10 Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma 06/02/10 Boston
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News 11/19/09 Boston
Bing Partners with Wolfram Alpha, OVP Leads $30M Fate Deal, Redfin Rakes In $10M, & More Seattle-Area Deals News 11/17/09 Seattle
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells 11/16/09 National
Page 1 of 1